New Vernon, NJ, United States of America

Brian Alexander McKittrick

USPTO Granted Patents = 68 

 

Average Co-Inventor Count = 6.1

ph-index = 16

Forward Citations = 886(Granted Patents)


Inventors with similar research interests:


Location History:

  • Bloomfield, NJ (US) (1988 - 2008)
  • Vernon, NJ (US) (2009)
  • New Vernon, NJ (US) (2002 - 2021)

Company Filing History:


Years Active: 1988-2021

Loading Chart...
Loading Chart...
68 patents (USPTO):

Title: Brian Alexander McKittrick: Innovator in Pharmaceutical Patents

Introduction

Brian Alexander McKittrick, hailing from New Vernon, NJ, has made significant contributions to the field of pharmaceuticals, holding an impressive total of 68 patents. His work primarily revolves around the development of novel therapeutics, particularly in the realm of anticoagulant agents.

Latest Patents

Among his latest innovations are several patents related to Factor XIIa inhibitors. These inventions provide compounds of specific formulas that serve as selective inhibitors of Factor XIIa. The pharmaceutical compositions derived from these compounds are designed for the treatment or prevention of thromboses, embolisms, hypercoagulability, and fibrotic changes. His contributions in this area highlight the potential to enhance patient care through better therapeutic strategies for managing clotting disorders.

Career Highlights

Brian has had a notable career, working with prominent organizations such as Schering Corporation and Merck Sharp & Dohme Corporation. His experiences in these leading pharmaceutical companies have undoubtedly shaped his expertise in drug development and patenting processes.

Collaborations

Throughout his career, Brian has collaborated with talented colleagues, including Zhaoning Zhu and Andrew William Stamford. These partnerships have played a crucial role in advancing his research and contributed to the successful development of his numerous patents.

Conclusion

Brian Alexander McKittrick stands out as a key figure in the pharmaceutical industry, particularly with his innovative developments in Factor XIIa inhibitors. His dedication to advancing medical science through patentable inventions continues to impact the field positively, offering new avenues for therapeutic intervention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…